CureLauncher connects patients who cannot find a cure for what ails them -- or in some cases what is killing them -- with clinical trials offering cutting-edge treatments.
"Clinical trials offer drugs and treatments that can still be years away from market, but some patients can't wait," said David Fuehrer, president and co-founder of the new company.
"Many miss out on potentially beneficial treatments because they don't know how to connect," he said.
Only 4 percent of Americans know how to find a clinical trial, according to the Center of Information and Study on Clinical Research Participation.
Meanwhile, trial sites across the country face delays because they need more participants.
The free CureLauncher service uses a patent-pending matching system to connect those with chronic disease to one or more of the nation's 20,000 trials that are accepting participants.
By helping these two groups connect, the founders hope to not only help the more than 200 million Americans living with chronic diseases, but also help bring better treatments to the market faster.